While Nrf2 has protective effects against various cancer types [44,45], some studies have suggested Nrf2 activation can have negative effects by elevating the antioxidant response that contributes to a resistance to cancer treatments [46,47,48]. The gene discussed is NFE2L2; the disease is cancer.